Offering safe affordable family-forming programs for everyone, including vulnerable or under-served employee populations, represents an opportunity for employers to build a caring culture that also will benefit the bottom line.
Ovia Health unveiled a new fertility and family-building benefit for employers and health plans that includes financial support, care navigation services and one-on-one concierge support.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Amazon selected Maven Clinic to provide fertility and family building support to its global employees across 50 countries. This includes support from care advocates and unlimited access to its virtual specialists like OB/GYNs and reproductive endocrinologists.
A new startup named Zuri Fertility recently launched. Its platform provides resources for patients who are trying to conceive — including telehealth, at-home testing, prescriptions, mental health services, education and care coordination.
Through Morgan Health's $25 million investment, Kindbody will continue expanding into new markets. It will also grow its services, including menopause treatment and male fertility.
Through Maven's acquisition, Naytal’s over 50 providers will join Maven’s platform, more than doubling the company’s number of providers in the U.K. Maven will also be able to sign on additional U.K.-based clients.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Medical device company Contraline became the first to implant a hydrogel-based male contraceptive gel into humans in a clinical trial. Implanted during a noninvasive 10-minute office procedure, the gel promises to block the flow of sperm to the vas deferens. If proven safe and effective, it could become the first nonhormonal, reversible contraceptive for men on the market.
Bay Area startup Counsyl aims to bring carrier screening to the mainstream, so that parents can know if their child is likely to have a serious genetic disease.